We saw a strong performance by major biotech players, but a challenging environment for the rest of the industry. Read more in our 2013 industry report
Beyond Borders: global biotech report 2013
Life Sciences deal sentiment scorecard
mHealth: Mobile tech poised to enable new era in health care
Cash on the prescription 2012
Beyond borders: global biotech report 2012
Pharma's $100 billion growth gap
Progressions 2012: health care everywhere
What Europe has to offer biotechnology companies
Medical technology report 2011
Finding sustainability in biotechnology, pharmaceutical and medical technology
Amplified business decisions are the new norm in today’s environment of rapid change in health care.
The life sciences community must explore a new course to address the changing climate — one driven by patients and focused on health outcomes.
From new market entrants and regulatory reform to expiring patents and rising prevalence of chronic disease, there are a myriad of hurdles to overcome.
Our Global Life Sciences Center brings together a worldwide team of professionals to help you achieve your potential.
We cover key issues in these areas: